EQS-News: Lifequest’s Wholly Owned Subsidiary Receives an Order for 40,000 Liters/Day Sewage Wastewater Treatment Plant From a Hospital 02.12.2022, 15:45 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
LifeQuest World 0,0104 USD -13,33 % Nasdaq OTC

EQS-News: LIFEQUEST WORLD CORP / Key word(s): Incoming Orders
Lifequest’s Wholly Owned Subsidiary Receives an Order for 40,000 Liters/Day Sewage Wastewater Treatment Plant From a Hospital

02.12.2022 / 15:45 CET/CEST
The issuer is solely responsible for the content of this announcement.


Lifequest’s Wholly Owned Subsidiary Receives an Order for 40,000 Liters/Day Sewage Wastewater Treatment Plant From a Hospital

RIDGEFIELD PARK, NJ

LIFEQUEST WORLD CORP (LQWC) is focused on innovative, decentralized, scalable wastewater treatment and reuse technologies. Through its wholly owned subsidiary, Biopipe India Private Limited, the Company is concurrently pursuing both industrial (ETP) and sewage wastewater treatment (STP) markets.

Tanmay Pawale, the CEO of Biopipe India Private Limited, stated that, “Biopipe has secured an order from a renowned multi-specialty hospital in Nashik, India. India is rapidly moving towards decentralized sewage treatment systems and for the past year and a half we have been working to establish a foothold in the decentralized wastewater treatment market for hospitals. Biopipe stands out against competition in terms of space and energy savings, no odor, no sludge and quality of treated wastewater. The small footprint of the Biopipe STP allowed the hospital to free up space to accommodate other utility systems in the allotted area.”

Enes Kutluca, the CEO of Biopipe Global Corp, stated that, “It has been observed that the intrinsic toxicity of hospital effluents could be 5 to15 times more than an urban effluent. Hospital sewage/wastewater can contaminate surface and ground water with a variety of potentially harmful substances, posing significant risks to people and the environment. Hospital sewage wastewater treatment is therefore essential. Biopipe systems is the best suited sewage treatment plant for hospitals in urban settings where onsite treatment is the only option.”  

About Lifequest & Biopipe

Lifequest offers effluent treatment plants (ETP), sewage treatment plants (STP), fat oil and grease (FOG) separator and hybrid media for water polishing. Biopipe has developed a patented, 100% sludge-free, chemical-free, odor-free, silent, easy to assemble and install, scalable, low cost, ecological and low maintenance-free onsite sewage wastewater treatment system.  The Abrimix ETP solution available through our joint venture is a highly efficient and cost-effective industrial wastewater treatment system that is vastly superior to Dissolved Air Floatation (DAF) and other onsite industrial wastewater treatment systems.

www.lifequestcorp.com

https://www.biopipe.co/

Contact: tanmay@lifequestcorp.com

Phone: 646-201-5242

This press release contains forward-looking statements that reflect the Company's current beliefs, expectations or intentions regarding future events.  Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements.  Words such as “will,” “will be”, “anticipate,” “predict,” “expect,” “continue,” “future,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of the Company and are difficult to predict.  Examples of such risks and uncertainties include, but are not limited to: political unrest in countries we operate in, Covid-19 pandemic related disruptions, shipping constraints, expatriation of invested capital, defaults, future revenues, expenditures, capital, the adequacy of the Company's current cash and working capital to fund present and planned operations, investments and the growth through joint ventures. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, can be found in our current Disclosure Statements at www.otcmarkets.com. The Company anticipates that subsequent events and developments may cause views and expectations to change. The Company assumes no obligation, and specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.



02.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


1504351  02.12.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1504351&application_name=news&site_id=boersennews
Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Weitere News

Gestern 22:29 Uhr • Artikel • dpa-AFX

Gestern 22:18 Uhr • Artikel • dpa-AFX

Gestern 21:01 Uhr • Artikel • dpa-AFX

Gestern 20:53 Uhr • Artikel • dpa-AFX

Gestern 20:40 Uhr • Artikel • dpa-AFX

Gestern 20:25 Uhr • Artikel • dpa-AFX

Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer